Physician profile
John M Ferguson
NPI 1952562969
$1,494.82
in general payments reported to CMS, 2019-2025
19 companies · $780 in 2025
The $780 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.65 · 2020: $26.44 · 2022: $153 · 2023: $114 · 2024: $382 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $340.82 | 2024-2025 | |
| Lilly USA, LLC | $318.19 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $161.43 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $121.34 | 2020-2025 | Shingrix, Arexvy |
| Amgen INC. | $82.15 | 2024-2025 | Evenity, Prolia, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.15 | 2022-2024 | Jardiance |
| Dexcom, INC. | $45.86 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $44.24 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Abbott Laboratories | $43.49 | 2023-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $42.97 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $40.32 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $29.78 | 2019-2024 | Eliquis |
| Boston Scientific Corporation | $27.26 | 2025 | Wavewriter Alpha Prime 16 |
| Genentech USA, INC. | $26.86 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $24.82 | 2025 | Gvoke Hypopen |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $23.09 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Astrazeneca Pharmaceuticals LP | $15.38 | 2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $15.26 | 2023 | Xarelto |
| Allergan, INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.